Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $81.68 million. The enterprise value is $156.08 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 73.59 million shares outstanding. The number of shares has increased by 16.14% in one year.
| Current Share Class | 73.59M |
| Shares Outstanding | 73.59M |
| Shares Change (YoY) | +16.14% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 5.33% |
| Owned by Institutions (%) | 72.32% |
| Float | 61.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.34 |
| PS Ratio | 0.26 |
| Forward PS | 0.27 |
| PB Ratio | 0.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 110.23 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.89 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.78 |
Financial Efficiency
Return on equity (ROE) is -58.26% and return on invested capital (ROIC) is -4.56%.
| Return on Equity (ROE) | -58.26% |
| Return on Assets (ROA) | -3.96% |
| Return on Invested Capital (ROIC) | -4.56% |
| Return on Capital Employed (ROCE) | -10.45% |
| Weighted Average Cost of Capital (WACC) | 12.11% |
| Revenue Per Employee | $259,280 |
| Profits Per Employee | -$148,312 |
| Employee Count | 1,200 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $716,000 in taxes.
| Income Tax | 716,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.17% in the last 52 weeks. The beta is 1.78, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -75.17% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 25.68 |
| Average Volume (20 Days) | 1,018,598 |
Short Selling Information
The latest short interest is 6.75 million, so 9.17% of the outstanding shares have been sold short.
| Short Interest | 6.75M |
| Short Previous Month | 5.72M |
| Short % of Shares Out | 9.17% |
| Short % of Float | 10.98% |
| Short Ratio (days to cover) | 6.99 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $311.14 million and -$177.97 million in losses. Loss per share was -$2.55.
| Revenue | 311.14M |
| Gross Profit | 154.63M |
| Operating Income | -43.17M |
| Pretax Income | -177.26M |
| Net Income | -177.97M |
| EBITDA | -5.17M |
| EBIT | -43.17M |
| Loss Per Share | -$2.55 |
Full Income StatementBalance Sheet
The company has $95.73 million in cash and $171.24 million in debt, with a net cash position of -$75.51 million or -$1.03 per share.
| Cash & Cash Equivalents | 95.73M |
| Total Debt | 171.24M |
| Net Cash | -75.51M |
| Net Cash Per Share | -$1.03 |
| Equity (Book Value) | 245.78M |
| Book Value Per Share | 3.41 |
| Working Capital | 79.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $731,000 and capital expenditures -$968,000, giving a free cash flow of -$237,000.
| Operating Cash Flow | 731,000 |
| Capital Expenditures | -968,000 |
| Depreciation & Amortization | 38.00M |
| Net Borrowing | -232.29M |
| Free Cash Flow | -237,000 |
| FCF Per Share | -$0.00 |
Full Cash Flow StatementMargins
Gross margin is 49.70%, with operating and profit margins of -13.87% and -57.20%.
| Gross Margin | 49.70% |
| Operating Margin | -13.87% |
| Pretax Margin | -56.97% |
| Profit Margin | -57.20% |
| EBITDA Margin | -1.66% |
| EBIT Margin | -13.87% |
| FCF Margin | n/a |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.14% |
| Shareholder Yield | -16.14% |
| Earnings Yield | -220.87% |
| FCF Yield | -0.29% |
Analyst Forecast
The average price target for Health Catalyst is $2.53, which is 127.93% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.53 |
| Price Target Difference | 127.93% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -2.66 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.66 |
| Piotroski F-Score | 5 |
